| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/03/2007 | CN1889960A Novel dipeptidyl peptidase IV inhibitors used for functionally influencing different cells and treating immunological, infammatory, neuronal, and other diseases |
| 01/03/2007 | CN1889951A Substituted benzazoles and methods of their use as inhibitors of RAF kinase |
| 01/03/2007 | CN1889922A Use of osteopontin in dental formulations |
| 01/03/2007 | CN1887883A V-shaped conjugated light-absorbing organic salt compound and its use |
| 01/03/2007 | CN1887875A Pyridazinyl amine derivative and its use in preparing small RNA virus inhibitor |
| 01/03/2007 | CN1887872A Tetrahydro isoquinoline derivative and its prepn process and medicine use |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293073C Teterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-Hydroxytryptamine-6-ligands |
| 01/03/2007 | CN1293072C Heterocyclyloxy-thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/03/2007 | CN1293071C Benzo [g] quinoline derivatives for treating glaucoma and myopia |
| 01/03/2007 | CN1293070C Quinoline derivatives |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293057C Ethylenediamine derivatives |
| 01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/03/2007 | CN1293053C 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | US7157582 For example, 3S,4aR,6S,8aR Ethyl 6-(((5S)-5-(Ethoxycarbonyl)-3-oxopyrrolidinyl) methyl)-2-methoxycarbonyl-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylate; for treating or preventing migraine |
| 01/02/2007 | US7157580 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/02/2007 | US7157579 Process for producing pyridine compound |
| 01/02/2007 | US7157577 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors |
| 01/02/2007 | US7157561 Methods of inhibiting transmission of a costimulatory signal of lymphocytes |
| 01/02/2007 | US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157476 Aminofurazan compounds useful as protein kinase inhibitors |
| 01/02/2007 | US7157475 Diamide invertebrate pest control agents |
| 01/02/2007 | US7157474 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
| 01/02/2007 | US7157473 Heterocyclic imines such as 2,2-Dichloro-N-[2-[3-(2-chloro-6-fluorophenyl)-5-isoxazolyl]-(4-pyridyl)]Acetamide, used for prophylaxis of hepatitis C virus (HCV) |
| 01/02/2007 | US7157472 N-alkylpiperdino-4-yl-urea-pyrazole derivative for treating obesity, metabolic disorders, eating disorders and diabetes |
| 01/02/2007 | US7157470 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157468 Pyrazole derivatives |
| 01/02/2007 | US7157467 Therapeutic use |
| 01/02/2007 | US7157464 Substituted piperazines |
| 01/02/2007 | US7157463 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 01/02/2007 | US7157462 Therapeutic agents useful for treating pain |
| 01/02/2007 | US7157455 4-Aminopyrimidine-5-one derivatives |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157442 Antibacterial compound |
| 01/02/2007 | US7157079 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/02/2007 | CA2373999C Pyrazinone thrombin inhibitors |
| 01/02/2007 | CA2274464C Ketobenzamides as calpain inhibitors |
| 12/28/2006 | WO2006138259A2 Chemokine receptor binding compounds |
| 12/28/2006 | WO2006138218A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/28/2006 | WO2006138148A1 Pesticidal 5-bis(methoxymethyl)aminopyrazole derivatives |
| 12/28/2006 | WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137485A1 Novel nitrogenated heterocyclic compound and salt thereof |
| 12/28/2006 | WO2006137465A1 Nitrogenated heterocyclic derivative |
| 12/28/2006 | WO2006136945A1 METABOLITES OF 1_ [_6- (1-ETHYL-l-HYDROXY-PROPYL) -PYRIDIN-3-YL] -3- [2- (4-METHYL-PIPERAZIN-I-YL) -BE NZYL] -PYRR0LIDIN-2-0NE AS SERATONIN RECEPTOR ANTAGONISTS |
| 12/28/2006 | WO2006136924A1 Histamine-3 receptor antagonists |
| 12/28/2006 | WO2006136917A1 Triazolylpiperidine derivatives and use thereof in therapy |
| 12/28/2006 | WO2006136857A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors |
| 12/28/2006 | WO2006136829A2 Pyrazole derivatives and their use as pka and pkb modulators |
| 12/28/2006 | WO2006136823A1 Heterocyclic containing amines as kinase b inhibitors |
| 12/28/2006 | WO2006136821A1 Pharmaceutical compounds |
| 12/28/2006 | WO2006136606A2 Oxindole derivatives |
| 12/28/2006 | WO2006136563A1 2-substituted benzimidazoles |
| 12/28/2006 | WO2006136562A1 Heterocyclylaminoalkyl substituted benzimidazoles |
| 12/28/2006 | WO2006136561A1 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 12/28/2006 | WO2006136553A1 Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 12/28/2006 | WO2006136552A2 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
| 12/28/2006 | WO2006136305A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
| 12/28/2006 | WO2006136101A1 Glucagon like peptide-1 receptor (glp-1r) regulators, preparation methods and uses |
| 12/28/2006 | WO2006105222A3 Carboxamide inhibitors of tgfb |
| 12/28/2006 | WO2006060381A3 N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| 12/28/2006 | WO2006058648A3 Biaryloxymethylarene carboxylic acids |
| 12/28/2006 | WO2006055463A3 2-amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 12/28/2006 | US20060293536 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 12/28/2006 | US20060293519 Method for producing cyclic diamine derivative or salt thereof |
| 12/28/2006 | US20060293371 Prodrug and process for producing the same |
| 12/28/2006 | US20060293363 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles |
| 12/28/2006 | US20060293354 Pyrimidine derivatives and their use as CB2 modulators |
| 12/28/2006 | US20060293351 Promotion of wound healing |
| 12/28/2006 | US20060293347 Pharmaceutically active compounds |
| 12/28/2006 | US20060293342 Tie-2 modulators and methods of use |
| 12/28/2006 | US20060293340 2-Aminopyrimidine derivatives as raf kinase inhibitors |
| 12/28/2006 | US20060293339 Biaryl substituted 6-membered heterocycles as sodium channel blockers |
| 12/28/2006 | US20060293337 P2x7 receptor antagonists and their use |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293314 4- Piridinylmethylsulphonamide derivatives as fungicidal plant protein agents |
| 12/28/2006 | US20060293313 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; shows high affinity for both the dopamine D2 receptor and the serotonin reuptake site, useful for treating central nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | US20060293303 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 12/28/2006 | US20060293299 3-((1S)-1-{1-[(S)-(3-cyanophenyl)(4-cyanophenyl)methyl]azetidin-3-yl}-2-fluoro-2-methylpropyl)-5-fluorobenzonitrile and its salts; antagonists and inverse agonists of the Cannabinoid-1 receptor |
| 12/28/2006 | US20060293298 Compounds |
| 12/28/2006 | DE102005028845A1 New substituted pyrrolidin-2-ones, piperidin-2-ones and isothiazolidine-1,1-dioxides useful for treating e.g. dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, breast cancer and heart failure |
| 12/28/2006 | CA2613261A1 Heteroaryl derivatives for treating viruses |
| 12/28/2006 | CA2612451A1 Oxindole derivatives |
| 12/28/2006 | CA2612325A1 Chemokine receptor binding compounds |
| 12/28/2006 | CA2612268A1 Metabolites of 1-[6-(1-ethyl-1-hydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one as seratonin receptor antagonists |
| 12/28/2006 | CA2612265A1 2-substituted benzimidazoles |
| 12/28/2006 | CA2612264A1 Heterocyclylaminoalkyl substituted benzimidazoles |
| 12/28/2006 | CA2612263A1 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 12/28/2006 | CA2612112A1 Process for the production of intermediates for the preparation of tricyclic benzimidazoles |
| 12/28/2006 | CA2612105A1 Chemokine receptor binding compounds |